CAMBRIDGE, Mass., Feb 11, 2008 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it intends to offer, subject to market and other conditions, 6,000,000 shares of its common ...

Vertex's cystic fibrosis portfolio has been a raging success for the company. The biotech’s next potential product addresses the extremely common problem of pain -- and could become its next ...

- 11.5 million shares of common stock at $38.50 per share for gross proceeds of $442.8 million - CAMBRIDGE, Mass., Dec 02, 2009 (BUSINESS WIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) ...

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment, and that business generates billions of dollars in annual revenue. The biotech has treatment candidate in another indication ...

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) ("Vertex” or the "Company”), a leading global provider of indirect tax solutions, today announced financial results ...

CAMBRIDGE, Mass. Bondholders in a biotech company that develops drugs for such serious diseases as viral infections, cancer and cystic fibrosis have agreed to convert their notes to common stock.

In recent trading activity, the 2020 Irrevocable Trust for the Benefit of Nicholas A. Shuhan, a significant shareholder in Vertex (NASDAQ:VRTX), Inc. (NASDAQ:VERX), has sold a substantial number of ...

RESTON, Va., Nov. 12, 2025 /PRNewswire/ -- V2X, Inc. (VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.25 million shares of its common stock on an ...

KING OF PRUSSIA, Pa., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, announced today the pricing of an ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Wheeler designed of “cones with a ...

MCLEAN, Va., Aug. 8, 2025 /PRNewswire/ -- V2X, Inc. (VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.0 million shares of its common stock on an underwritten ...

KING OF PRUSSIA, Pa., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, announced today the launch of a proposed ...